References

  1. Ferrer Baixaulí F, Vento Torres D, Martínez Lorente A, Llombart Bosch A, Carda Batalla C, Marco Algarra J. Angiosarcoma of the outer ear: A case report. Acta Otorrinolaringol Esp. 1999;50(4):311-4. PubMed | Google Scholar

  2. Durbeca M, Couloignerb V, Troncheb S, Albertc S, Kanitakisd J, Ltaief Boudriguae A, Malardf O, Maubecg E, Mourrain Langloish E, Navaillesi B, Peuvrelj L, Phulpink B, Thimonniera J-C, Disanta F, Dolivetl G. Recommandations de la SFORL. Bilan d’extension et principes d’exérèse des tumeurs de la face et du cou à point de départ cutané. Annales françaises d’oto-rhino-laryngologie et de pathologie cervico-faciale.2014 ; 131: 360-369. Google Scholar

  3. Abdulhafez Selim, Amor Khachemoune, Norman Lockshin A. Angiosarcoma: A Case Report and Review of the Literature. continuing medical education. 2005;76(5):313-317. PubMed | Google Scholar

  4. Leighton SE, Levine TP. Angiosarcoma of the external ear: a case report. Am J Otol. 1991;12(1):54-56. PubMed | Google Scholar

  5. Claudia Andrä, Josefine Rauch, Minglun Li, Ute Ganswindt, Claus Belka, Ladan Saleh-Ebrahimi, Hendrik Ballhausen, Silke Birgit Nachbichler, and Falk Roeder. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck. Radiat Oncol. 2015;10:140. PubMed | Google Scholar

  6. Mark RJ, Tran LM, Sercarz J et al. Angiosarcoma of the head and neck: The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg. 1993;119(9):973-978. PubMed | Google Scholar

  7. Budd GT. Management of angiosarcoma. Curr Oncol Rep. 2002;4(6):515-519. PubMed | Google Scholar

  8. Fujisawa Y, Yoschino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: A multicentre, retrospective study. British Journal of Dermatology. 2014;171(6):1493-1500. PubMed | Google Scholar

  9. Fury MG, Antonescu CR, Van Zee KJ et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with sugery and chemotherapy. Cancer J. 2005;11(3):241-247. PubMed | Google Scholar

  10. Fayette J, Martin E, Piperno-Neumann S et al. Angiosarcomas, a herogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18(12):2030-2036. PubMed | Google Scholar

  11. Fata F, O’Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999; 86(10):2034-2037. PubMed | Google Scholar

  12. Penel N, Binh NB, Bay JO et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the AngioTax study. J Clin Oncol. 2008;26(32):5269-5274. PubMed | Google Scholar

 

 

 

 

 

 

 

 

<